Lexicon Pharmaceuticals | LXRX - Capital Y Las Reservas

Precio De Mercado
2.34
Cambio Diario
0.34 16.75%
Mensual
32.67%
Anual
233.10%
Q2 Expectativa
1.96




Capital Y Las Reservas Cambio Fecha
Abbott USD 52.06B 69M 2026-03
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Illumina USD 2.68B 47M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 81.19B 358M 2026-03
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
MacroGenics USD 55.59M 11.41M 2025-12
MannKind USD -59.2M 8.17M 2026-03
Merck USD 45.88B 6.73B 2026-03
Moderna USD 7.41B 1.24B 2026-03
Novartis USD 38.93B 7.2B 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12